Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Amortizatization of Intangibles (2022 - 2025)

Ovid Therapeutics (OVID) has disclosed Amortizatization of Intangibles for 4 consecutive years, with $300000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Amortizatization of Intangibles rose 8.3% year-over-year to $300000.0, compared with a TTM value of $1.2 million through Sep 2025, up 8.18%, and an annual FY2024 reading of $1.1 million, up 6.71% over the prior year.
  • Amortizatization of Intangibles was $300000.0 for Q3 2025 at Ovid Therapeutics, up from $294000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $354185.0 in Q2 2022 and bottomed at $253000.0 in Q1 2023.
  • Average Amortizatization of Intangibles over 4 years is $276864.3, with a median of $269000.0 recorded in 2024.
  • The sharpest move saw Amortizatization of Intangibles fell 27.16% in 2023, then increased 8.3% in 2025.
  • Year by year, Amortizatization of Intangibles stood at $254970.0 in 2022, then increased by 2.36% to $261000.0 in 2023, then rose by 8.05% to $282000.0 in 2024, then rose by 6.38% to $300000.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for OVID at $300000.0 in Q3 2025, $294000.0 in Q2 2025, and $288000.0 in Q1 2025.